Psyence Biomedical Ltd. (PBM)
NASDAQ: PBM · Real-Time Price · USD
0.5498
+0.0878 (19.00%)
At close: Apr 25, 2025, 4:00 PM
0.5533
+0.0035 (0.64%)
Pre-market: Apr 28, 2025, 5:24 AM EDT

Psyence Biomedical Cash Flow Statement

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022
Period Ending
Sep '24 Mar '24 Mar '23 Mar '22
Net Income
-46.59-51.16-3.21-1.86
Depreciation & Amortization
00--
Stock-Based Compensation
0.60.320.220.33
Other Operating Activities
44.1649.07-0.08-
Change in Accounts Receivable
-0.110.11-0.110.1
Change in Accounts Payable
-0.79-1.041.660.03
Change in Other Net Operating Assets
-0.14-0.25-0.070
Operating Cash Flow
-2.87-2.95-1.59-1.4
Capital Expenditures
-0.01-0.01--
Other Investing Activities
----0.03
Investing Cash Flow
-0.01-0.01--0.03
Short-Term Debt Issued
-2.5--
Total Debt Issued
2.792.5--
Short-Term Debt Repaid
--0.15--
Total Debt Repaid
-0.15-0.15--
Net Debt Issued (Repaid)
2.642.35--
Other Financing Activities
-0.14-1.17-1.63
Financing Cash Flow
4.212.351.17-1.63
Miscellaneous Cash Flow Adjustments
00--
Net Cash Flow
1.33-0.6-0.42-3.06
Free Cash Flow
-2.89-2.95-1.59-1.4
Free Cash Flow Per Share
-4.76-33.96-23.88-
Levered Free Cash Flow
-0.4-1.71-0.32-
Unlevered Free Cash Flow
-0.38-1.68-0.32-
Change in Net Working Capital
-1.050.27-1.48-
Updated Jan 23, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q